Bausch + Lomb Responds to Rumors of a Potential Sale
Friday, December 13 2024 | 09 h 17 min | News
Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization...
Read MoreBausch + Lomb Receives Health Canada Approval for Soothe® Antibiotic Drops
Wednesday, October 23 2024 | 13 h 38 min | News
Bausch + Lomb Corporation announced Health Canada has approved Soothe Antibiotic Drops, an over-the-counter drop to treat external infections of the...
Read MoreBausch + Lomb Collects More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Through Innovative Recycling Programs
Tuesday, April 23 2024 | 13 h 40 min | News
Bausch + Lomb announced its ONE by ONE and Biotrue® Eye Care Recycling programs have collected 84,343,540 units, or...
Read MoreBausch Advances Novel Dry Eye Therapeutic to Phase 3
Tuesday, December 29 2020 | 07 h 28 min | Dry Eye, Latest News, News, Vision Science
Quebec based B+L has announced the second of two Phase 3 studies studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a...
Read MoreUS Ad Monitor Recommends B+L Discontinue Claims About PeroxiClear
Monday, December 5 2016 | 00 h 00 min | News
Bausch + Lomb has voluntarily agreed to discontinue certain claims about PeroxiClear product, such as superior comfort over Clear Care, but was able...
Read More